Vienna BioCenter is a leading life sciences campus in Europe, with a unique combination of research, education, and companies on a single campus. It boasts a significant presence with 2,800 employees, 1,500 students, 145 research groups, and 39 biotech companies. Established in 1988, it has evolved into a multi-disciplinary biomedical research center that attracts substantial private and public funding. The campus hosts a diverse range of players including universities, research institutions, biotech companies, as well as private and public service organizations, setting it apart from other biotech clusters. With a strong focus on vaccines, immunology, disease diagnostics, and research reagents, the campus expands across 90,000m2 and is home to 34 members. The VBC Core Facilities, Lecture Series, and the prestigious VBC PhD Program underscore its commitment to excellence. As a prominent hub for life sciences, Vienna BioCenter presents an exciting opportunity for investment and collaboration.
There is no investment information